Chui-Se Tham

Chui-Se Tham is a Manager of Lab Operations at Dyne Therapeutics since 2021, with prior experience as a Field Application Scientist at MESO SCALE DIAGNOSTICS, LLC. and a Senior Scientist at Mitobridge, where novel targets based on mitochondrial biology were identified and validated. Chui-Se Tham’s extensive background includes roles such as Senior Scientist at EMD Serono, focusing on multiple sclerosis drug discovery, Research Scientist II at Xenon Pharmaceuticals supervising pain projects, and contributions to pain and neuroinflammatory research at Johnson & Johnson. Chui-Se Tham has also worked as a Scientist at Kalypsys Inc. and Merck, and was involved in pharmacological assessments and target characterization at Allelix Neuroscience Inc. and the University of British Columbia. Education includes a Bachelor's Degree in Biology from the University of British Columbia and Medical Interpreter Certificates in Mandarin and Cantonese from Interpreters Associates Inc.